Add BrightSurf on Google Email

UMBC researchers identify promising new target for ovarian cancer treatment

Researchers at the University of Maryland Baltimore County have identified USP15 as a promising new target for ovarian cancer treatment, which appears to rely on the enzyme for survival, division, and spread. Reducing USP15 levels makes cancer cells more sensitive to chemotherapy drugs, potentially leading to less harm to healthy cells.

SourceUniversity of Maryland Baltimore County·JournalMolecular Therapy Oncology·TypeExperimental study·DateSep 24, 2026

Protein linked to cell death may also drive liver cancer

Research identifies MLKL as a protein that helps drive liver cancer associated with obesity-related fatty liver disease by reducing mitochondrial function, promoting tumor development. Removing MLKL reduces liver tumors but not fatty liver or liver inflammation, suggesting a new therapeutic target for liver cancer treatment

SourceUniversity of Oklahoma·JournalHepatology·TypeExperimental study·DateSep 10, 2026

Cellular recycling protein plays critical protective role in the gut

Researchers at Olivia Newton-John Cancer Research Institute discovered that reduced BECLIN1 levels weaken the gut's protective barrier, leading to increased susceptibility to inflammation and disease. This finding may help explain why some people are more susceptible to gut inflammation and associated diseases.

SourceOlivia Newton-John Cancer Research Institute·JournalCell Death and Disease·TypeExperimental study·DateJul 12, 2026

Inducing cell death in pancreatic cancer cells

A team of researchers has identified a previously unknown vulnerability in KRAS-mutated pancreatic cancer cells, making them susceptible to necroptosis. Blocking the tumor cells' defense mechanism by inhibiting caspase-8 leads to significant cell death and reduced tumor growth.

SourceUniversity of Cologne·JournalNature Communications·TypeExperimental study·DateJun 16, 2026

A molecular switch in ferroptosis

A study by Zhejiang University researchers reveals that TATA box-binding protein-associated factor 1 (TAF1) acts as a context-dependent molecular switch regulating ferroptosis in cancer cells. In <em>TP53</em>-mutant tumors, TAF1 promotes nGPX4 degradation, increasing ferroptosis susceptibility. Conversely, in <em>TP53</em>-wild-type t...

Flatworms reveal explosive new type of immune cell

Researchers at Stanford University have identified a new type of immune cell called ruptoblasts in flatworms, which can kill surrounding cells through an explosive process called ruptosis. This discovery could hold important insights for modern medicine and may lead to targeted treatments for bacterial infections or tumors.

SourceStanford University·JournalCell·DateJun 2, 2026

Beyond cell death: The hidden drivers of stem cell aging

A recent study reveals that MLKL activation causes direct damage to mitochondria, impairing energy production and leading to functional decline in hematopoietic stem cells. In contrast, deletion or inhibition of MLKL significantly alleviates these defects, suggesting a post-transcriptional mechanism driving HSC aging.

SourceThe Institute of Medical Science, The University of Tokyo·JournalNature Communications·TypeExperimental study·DateApr 16, 2026

New research identifies fatty acids that selectively induce death in senescent cells, opening new avenues for age-related therapies

A new study from the University of Minnesota Medical School has identified certain naturally occurring polyunsaturated lipids that selectively induce death in senescent cells, which are old and damaged cells that accumulate with age. These lipids trigger a process called ferroptosis, which can be used as a potential treatment for age-r...

SourceUniversity of Minnesota Medical School·JournalCell Press Blue·TypeExperimental study·DateMar 12, 2026

Altered copper metabolism is a crucial factor in inflammatory bone diseases

Copper metabolism plays a crucial role in inflammatory bone diseases, with copper overload suppressing glycogen synthesis and increasing inflammatory activity. Researchers found that cuproptosis, a form of programmed cell death, can lead to bone weakening and osteoclast formation, providing a potential new therapeutic target.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalInternational Journal of Oral Science·TypeExperimental study·DateMar 5, 2026

Itaconate modifications: mechanisms and applications

Researchers summarize itaconate biology highlighting its chemical reactivity and therapeutic potential in treating infectious diseases, sepsis, autoimmunity, neurodegenerative disorders. Itaconate exerts biological effects through post-translational modifications, altering protein activity and signaling pathways

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeLiterature review·DateJan 15, 2026

Chinese Medical Journal review highlights ZBP1’s role in programmed cell death and therapeutic potential

Researchers explore ZBP1-mediated programmed cell death, its mechanisms, and therapeutic strategies for systemic diseases. The review also discusses ZBP1's involvement in various types of cell death, including apoptosis, necroptosis, pyroptosis, and ferroptosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 22, 2025

Uncovering what makes cells picky (self)eaters: uOttawa team maps pathways that determine cellular recycling outputs

A team of researchers from the University of Ottawa has developed a new workflow to study autophagy, a fundamental cellular mechanism that preserves cell health by recycling and degrading worn-out components. The study reveals novel signaling mechanisms regulating autophagy in response to numerous disease-related stress conditions.

SourceUniversity of Ottawa·JournalJournal of Cell Biology·TypeComputational simulation/modeling·DateSep 4, 2025

Precursors to bone marrow cancer can stop themselves

Some precursor plasma cells in patients with MGUS and SMM enter cellular senescence, a dormant state that prevents cancer progression. In contrast, patients who develop bone marrow cancer lack this protective mechanism. The discovery offers hope for early intervention and potential treatments that promote or inhibit senescence.

SourceAarhus University·JournalLeukemia·TypeExperimental study·DateJun 27, 2025

Cellular scaffolding secrets unlocked: Scientists discover key to microtubule growth

Researchers from Queen Mary University of London and the University of Dundee have discovered how microtubules decide whether to grow or shorten, a fundamental mechanism governing cellular processes. This breakthrough sheds new light on cell division and opens potential avenues for cancer treatment.

SourceQueen Mary University of London·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 29, 2025

Unveiling the intricate mechanisms behind oxysterol-induced cell death

Researchers at Doshisha University reveal that 25-hydroxycholesterol causes a specific type of cell death called ferroptosis, which could contribute to various diseases. The study identifies two key mechanisms by which 25-OHC induces ferroptosis, including inhibition of cellular pathways and disruption of antioxidant systems.

SourceDoshisha University·JournalFree Radical Biology and Medicine·TypeExperimental study·DateFeb 20, 2025

Synthetic RIG-I-agonist RNA induces death of hepatocellular carcinoma cells

A synthetic retinoic acid-inducible gene I (RIG-I) agonist RNA has been shown to induce innate immune signaling and death of hepatocellular carcinoma cells in vitro. The addition of recombinant interferon-b potentiated this cell death, suggesting a potential new mechanism for treating patients with liver cancer.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Interferon & Cytokine Research·TypeExperimental study·DateFeb 19, 2025

Selenoproteins: The fountain of youth?

Researchers from Osaka University found that selenoproteins are essential for counteracting lipid peroxides and maintaining hematopoiesis in human cells. The study also showed that dietary Vitamin E can protect hematopoiesis and repair impaired B cell differentiation, providing potential strategies for fighting age-related diseases.

SourceOsaka University·JournalBlood·TypeObservational study·DateFeb 3, 2025